蜜芽app

Meeting Coverage >

NKF

Novel Drug Cuts Proteinuria in APOL1-Mediated Kidney Disease

Significant UPCR reductions in just a few weeks in phase II study

Even With CKD, Patiromer Helped Heart Failure Patients Keep Hyperkalemia at Bay

Promising findings from prespecified renal analysis of the DIAMOND trial

Which Factors Predict Rapid Decline in Polycystic Kidney Disease?

Researchers pinpointed six clinical variables predictive of rapid decline to ESRD

Flu a Consistent Threat to ESRD Patients

Those with advanced-stage kidney disease had 28% higher risk of in-hospital death

COVID-Related AKI Chronically Hard on Kidneys

More critically ill COVID patients developed CKD versus bacterial pneumonia patients

NKF 2021: Skewed Transplant Waitlists; Daft Diabetes Care

Other noteworthy research presented at the National Kidney Foundation's annual meeting

Post-Marketing Data Confirms Patiromer Safety in Hyperkalemia

Rates of death, serious adverse events lower than seen in clinical trial program

Are People on Dialysis Especially Wary of the COVID-19 Vaccine?

Some patients said they believed it was better to get a natural infection versus a vaccine

Pegloticase Safe for Dialysis Patients With Gout

Significant drop in monthly ESA dose seen after treatment, too

Diabetic Kidney Disease Risk Stratifier Helpful Tool for PCPs

Test result played into how primary care physicians managed these patients

Metformin Well Tolerated in Polycystic Kidney Disease

But next question is, will it work

CKD Care Took a Back Seat During Pandemic

Telehealth couldn't make up for lack of in-person healthcare visits

NKF 2020: New Lupus Tx; Staying on Spironolactone, and More

Research highlights from the National Kidney Foundation virtual meeting

Phosphate Binder Type Matters in Dialysis

Hospital admission rates, healthcare costs varied according to binder prescribed

Entresto in HF Tied to Less Kidney Decline

Meta-analysis shows trend favoring drug over ACE inhibitor or ARB alone

Phase II Success for Oral CKD-Related Pruritus Agent

Novel drug activates kappa opioid receptors

CKD, Uric Acid, and Heart Disease: What's the Link?

Stage 3 CKD patients with higher uric acid levels also saw worse heart health

Combo Tx Safely Cuts BP in CKD Patients with Hypertension

Spironolactone plus patiromer reduced risk for hyperkalemia

Apixaban May be Better Option in Patients with CKD and AFib

Meta-analysis shows lower incidence of future stroke, major bleeding versus warfarin

Trial Data Confirm: Veltassa, Lokelma Effective for Hyperkalemia

But agents' long-term safety and efficacy not yet established

NKF SCM18 Roundup: Refused Donor Kidneys, Medication Mgmt, and More

Other noteworthy research presented at NKF meeting

Serum Bicarbonate Tied to CKD Progression

Another use for multivariate risk equations

Invokana Helps Kidneys Even in Diabetic CKD

Subanalysis of CANVAS program shows slower progression, fewer events

Researchers: Screen Depressed Dialysis Patients for Suicidality

Depression more prevalent in dialysis population

Benefits, Drawbacks to Denosumab Tx in ESRD

High rates of treatment-related hypocalcemia

Readmissions High Among Peritoneal Dialysis Patients

Nearly a quarter readmitted within a month

NKF's Spring Meeting to Cover Wide Spectrum of Kidney Care

Interprofessional collaboration one theme of this year's meeting

Low-Dose Furosemide Didn't Prevent Worsening AKI

Loop diuretic tied to higher rates of electrolyte abnormalities in ICU

Early Prevention, Treatment Key in Diabetic Kidney Disease

Experts say technology basis for patient care and prevention

After Bariatric Surgery, Renal Nutrition Vital

Expert: dietitians must address these patients' special needs

Annual VA Spending for CKD Steadily Increasing

In 2014, costs reached an estimated $19 billion

Long-Term Statin Use Linked to Complications in T2D Patients

But patients not matched at baseline

Blood Pressure Drop for CKD Patients on Patiromer

Sub-analyses finds those with resistant hypertension see benefits

Fanconi Syndrome Seen With Off-Label Canagliflozin

T1D patient presented 1 week after starting drug

CKD Patients With Diabetes Have Altered Gut Bugs

Presence of certain microbes could boost inflammation

NKF: Kidney Transplant Patients Face Diabetes Risk

Meta-analysis findings may impact clinical management and follow-up

Nephrologists Iffy About Dialysis in Expectant Moms

Survey results suggest lack of clear guidelines leads to uncertainty.

Migraine Drug May Set Stage for Kidney Stones

ORLANDO - Patients who take topiramate (Topamax) therapy for treatment of migraine appear to deplete citrate in the urine, creating an environment for kidney stones, researchers reported here.

C. Diff Dangerous in ESRD

ORLANDO -- Kidney dialysis patients who are infected with Clostridium difficile have a greater risk of infection relapse and also have a higher all-cause mortality that patients who do not have kidney disease, researchers said here.

Facebook Status: Need Kidney

WASHINGTON -- Promoting living kidney donation on social networks could increase the organ donor pool, researchers said here.

1